MedCityNews INVEST PharmaTech – The State of AI in Drug Discovery

MedCityNews INVEST PharmaTech – The State of AI in Drug Discovery

449 views Aug 8, 2022 Artificial intelligence in healthcare is finally emerging from being overhyped to showing some practical applications. If it succeeds in the realms of drug discovery, that will be a monumental achievement helping both to speed up and lower the cost for drug development. Learn from experts about where we are in leveraging AI effectively for drug discovery. Moderator: Frank Vinluan, Senior Biopharma Reporter, MedCity News Speakers: Nathan Benaich, PhD, Founder and General Partner, Air Street Capital @nathanbenaich Chris Gibson, PhD, Co-founder and CEO, Recursion Najat Khan, PhD, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Pharmaceutical Richard Law, PhD, Chief Business Officer, Exscientia

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s